0001209191-19-056631.txt : 20191114
0001209191-19-056631.hdr.sgml : 20191114
20191114213927
ACCESSION NUMBER: 0001209191-19-056631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191108
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole G Bradley
CENTRAL INDEX KEY: 0001337798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 191222269
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-08
1
0001131324
GENOMIC HEALTH INC
GHDX
0001337798
Cole G Bradley
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
CFO
Common Stock
2019-11-08
4
D
0
27385
0.00
D
11794
I
Held by the Cole Family Trust
Common Stock
2019-11-08
4
D
0
11794
0.00
D
0
I
Held by the Cole Family Trust
Employee Stock Option (right to buy)
28.05
2019-11-08
4
D
0
1888
0.00
D
2023-01-31
Common Stock
1888
0
D
Employee Stock Option (right to buy)
30.84
2019-11-08
4
D
0
20000
0.00
D
2024-01-28
Common Stock
20000
0
D
Employee Stock Option (right to buy) Holding
31.12
2019-11-08
4
D
0
55000
0.00
D
2025-02-13
Common Stock
55000
0
D
Employee Stock Option (right to buy) Holding
27.00
2019-11-08
4
D
0
56558
0.00
D
2026-02-16
Common Stock
56558
5142
D
Employee Stock Option (right to buy) Holding
27.00
2019-11-08
4
D
0
5142
0.00
D
2026-02-16
Common Stock
5142
0
D
Employee Stock Option (right to buy) Holding
27.48
2019-11-08
4
D
0
38582
0.00
D
2027-01-31
Common Stock
38582
17538
D
Employee Stock Option (right to buy) Holding
27.48
2019-11-08
4
D
0
17538
0.00
D
2027-01-31
Common Stock
17538
0
D
Employee Stock Option (right to buy) Holding
33.21
2019-11-08
4
D
0
22894
0.00
D
2028-01-31
Common Stock
22894
29436
D
Employee Stock Option (right to buy) Holding
33.21
2019-11-08
4
D
0
29436
0.00
D
2028-01-31
Common Stock
29436
0
D
Employee Stock Option (right to buy) Holding
72.52
2019-11-08
4
D
0
27740
0.00
D
2029-01-29
Common Stock
27740
0
D
Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $753,089 and 12,335 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer resticted stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 9,026 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $30,130, less applicable tax withholdings, and 493 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $296,215, less applicable tax withholdings, and 4,851 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $808,254, less applicable tax withholdings, and 13,238 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $927,027, less applicable tax withholdings, and 15,184 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 3,935 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $624,767 less applicable tax withholdings, and 10,233 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 13,422 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $316,752, less applicable tax withholdings, and 5,188 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 22,528 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 21,230 shares of Exact Sciences common stock with an exercise price of $94.76 per share.
/s/ G. Bradley Cole, Attorney-in-fact
2019-11-14